Manufacturer record
Goodman Pharmaceuticals: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by Goodman Pharmaceuticals (Puducherry) were declared Not of Standard Quality between May 2019 and October 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: ONTT2404, Nicofast-5 (Nicorandil Tablets IP) (exp Feb 2027). Drugs Testing Laboratory, Chennai-06 (state lab) found it not of standard quality: Dissolution & Content. Listed in the October 2025 alert.
Records by type
3 records linked to Goodman Pharmaceuticals in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Nicofast-5 (Nicorandil Tablets IP) | Batch ONTT2404Mfg Mar 2025 · Exp Feb 2027 | Dissolution & ContentDissolution | Drugs Testing Laboratory, Chennai-06State lab | Oct 2025 |
| Telmisartan Tablets I.P. 20 mg (TELSAT ? 20) | Batch ST2T2302Mfg Mar 2024 · Exp Feb 2026 | The Sample does not conform to standard in respect of the test for Dissolution performedDissolution | State Drugs Testing Laboratory, Agartala, TripuraState lab | May 2025 |
| Atriflam (Aceclofenac, Paracetamol & Serratiopeptidase Tablets) | Batch SAMT1803Mfg Oct 2018 · Exp Sep 2020 | Assay of SerratiopeptidaseAssay | CDL KolkataCDSCO lab | May 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.